My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
June 2015
TOP STORIES
MERS: The Emergence Continues -- Learn the Latest at IDWeek

IDWeek has covered the developments of the Middle East Respiratory Syndrome (MERS) since the disease’s initial emergence in September 2012 and will continue to do so this year. 

IDWeek 2013’s Opening Plenary Panel discusses the MERS-CoV Outbreak featuring
Ziad Memish, MD, FACP, FIDSA, FSHEA, Deputy Minister
for Public Health in the Kingdom of Saudi Arabia.

John Watson, MD, MSc, a medical epidemiologist actively involved in the MERS-CoV control activities at the Centers for Disease Control and Prevention, will offer insight at IDWeek 2015 to be held October 7-11 in San Diego.  He will discuss the latest information concerning the epidemiology, clinical manifestations, and treatments for the disease.  

In the past month alone, MERS has rapidly spread with the latest outbreaks occurring in China and South Korea. Approximately 1,244 cases have been reported in a total of 25 countries with a mortality rate of 30% to 40%, according to the World Health Organization. As a fairly new disease to humans, there are no vaccines and no cures – its pathogenic potential and mode of transmission are still unknown.

Register now to attend this invigorating symposium taking place on Thursday, October 8

For further session information, view the interactive program.

Important Dates

Discounted Early Registration
July 24

Late Breaker Abstract Deadline
August 6 at 5 p.m. EDT

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


PATIENT CARE AND SCIENCE
FDA Cautions About Dose Confusion and Medication Errors for Antibacterial Drug Zerbaxa
Foundation to Develop Database of C. difficile Providers
CLINICAL PRACTICE MANAGEMENT
So Long SGR! What’s Next, and How Will MACRA Affect You?
CMS Proposes Changes to Meaningful Use Program; ONC Updates HIT Certification Criteria
IDSA Offers Discussion Board, Other Resources on Contract Negotiations
POLICY AND ADVOCACY
IDSA Members Urge Increased NIH Funding on Capitol Hill
Help HIVMA Advocate for HIV Funding and Syringe Exchange
HOPE Act Springs Forward
Weigh in on FDA Proposed Changes to Blood Donor Deferral Policy
Societies Provide Comments to NIH on Improving Impact and Sustainability of Biomedical Research
GLOBAL ID
Science Speaks: Global HIV, TB and Ebola Research and Responses
EDUCATION AND RESOURCES
IDSA Foundation Joins the Combined Federal Campaign
Courses in Antimicrobial Stewardship
Updated Lyme Disease Case Study Course
YOU AND YOUR COLLEAGUES
Reminder: CID Editor-in-Chief Search is On!
Members on the Move
Member Report
FROM THE PRESIDENT
Concerned About Changes to the ABIM MOC Program? IDSA is Working for You
TOP STORIES
Big Advances in Antibiotic Stewardship and R&D Policies
MERS: The Emergence Continues -- Learn the Latest at IDWeek
Thank You From IDSA
Journal Club
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'info@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.